title: A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors.
authors: Iman
authors: I
authors: Aouidad
authors: Charlotte
authors: C
authors: Fite
authors: Eduardo
authors: E
authors: Marinho
authors: Lydia
authors: L
authors: Deschamps
authors: Beatrice
authors: B
authors: Crickx
authors: Vincent
authors: V
authors: Descamps
mesh_terms: D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009570:Nitriles / Q000009:adverse effects* / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000473:pathology; D011759:Pyrrolidines / Q000009:adverse effects* / Q000627:therapeutic use; D012720:Severity of Illness Index; D000077597:Vildagliptin
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D009570:Nitriles; D011759:Pyrrolidines; D000077597:Vildagliptin; D000218:Adamantane